Telomir Pharmaceuticals is a preclinical stage company focused on the science of lengthening telomere caps, which the company believes will extend human lifespans and improve quality of life as people age. The company announced preclinical test results that showed Telomir-1 may help to reset the human body's epigenetic clock-potentially allowing humans to live longer and healthier lives.

05 Jun 2025
TELO: Price Target Raise on Aging Reversal News

Sign up for free to access
Get access to the latest equity research in real-time from 12 commissioned providers.
Get access to the latest equity research in real-time from 12 commissioned providers.
TELO: Price Target Raise on Aging Reversal News
Telomir Pharmaceuticals, Inc. (TELO:NAS) | 0 0 0.0%
- Published:
05 Jun 2025 -
Author:
Brad Sorensen -
Pages:
6 -
Telomir Pharmaceuticals is a preclinical stage company focused on the science of lengthening telomere caps, which the company believes will extend human lifespans and improve quality of life as people age. The company announced preclinical test results that showed Telomir-1 may help to reset the human body's epigenetic clock-potentially allowing humans to live longer and healthier lives.